company background image
BOD logo

Bod Science ASX:BOD Stock Report

Last Price

AU$0.024

Market Cap

AU$4.3m

7D

0%

1Y

-65.2%

Updated

20 Feb, 2024

Data

Company Financials

Bod Science Limited

ASX:BOD Stock Report

Market Cap: AU$4.3m

BOD Stock Overview

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. More details

BOD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Risk Analysis

Earnings have declined by 4.2% per year over past 5 years

Does not have a meaningful market cap (A$4M)

Negative shareholders equity

Shares are highly illiquid

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

Bod Science Limited Competitors

Argent BioPharma

ASX:RGT

AU$6.8m

Zelira Therapeutics

ASX:ZLD

AU$5.8m

Epsilon Healthcare

ASX:EPN

AU$7.2m

Ecofibre

ASX:EOF

AU$10.2m

Price History & Performance

Summary of share price highs, lows and changes for Bod Science
Historical stock prices
Current Share PriceAU$0.024
52 Week HighAU$0.13
52 Week LowAU$0.024
Beta1.45
1 Month Change0%
3 Month Change-7.69%
1 Year Change-65.22%
3 Year Change-94.95%
5 Year Change-95.10%
Change since IPO-91.72%

Recent News & Updates

Recent updates

Here's Why We're Watching Bod Australia's (ASX:BDA) Cash Burn Situation

Sep 23
Here's Why We're Watching Bod Australia's (ASX:BDA) Cash Burn Situation

Bod Australia (ASX:BDA) Is In A Good Position To Deliver On Growth Plans

Jun 07
Bod Australia (ASX:BDA) Is In A Good Position To Deliver On Growth Plans

Why Bod Australia's (ASX:BDA) CEO Pay Matters

Feb 22
Why Bod Australia's (ASX:BDA) CEO Pay Matters

Shareholder Returns

BODAU PharmaceuticalsAU Market
7D0%-0.9%0.5%
1Y-65.2%-2.5%9.9%

Return vs Industry: BOD underperformed the Australian Pharmaceuticals industry which returned 61.8% over the past year.

Return vs Market: BOD underperformed the Australian Market which returned 9.6% over the past year.

Price Volatility

Is BOD's price volatile compared to industry and market?
BOD volatility
BOD Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.9%
Market Average Movement7.9%
10% most volatile stocks in AU Market16.2%
10% least volatile stocks in AU Market3.1%

Stable Share Price: BOD has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BOD's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2014n/aJo Pattersonbodscience.com

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and distribution of therapeutics medicinal cannabis products for medical markets.

Bod Science Limited Fundamentals Summary

How do Bod Science's earnings and revenue compare to its market cap?
BOD fundamental statistics
Market capAU$4.26m
Earnings (TTM)-AU$7.95m
Revenue (TTM)AU$3.32m

1.3x

P/S Ratio

-0.5x

P/E Ratio

Is BOD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BOD income statement (TTM)
RevenueAU$3.32m
Cost of RevenueAU$1.05m
Gross ProfitAU$2.27m
Other ExpensesAU$10.22m
Earnings-AU$7.95m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.045
Gross Margin68.40%
Net Profit Margin-239.47%
Debt/Equity Ratio-136.9%

How did BOD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/02/20 12:06
End of Day Share Price 2023/11/23 00:00
Earnings2023/06/30
Annual Earnings2023/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bod Science Limited is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alexander SmithPAC Partners Securities Pty. Ltd.